title: Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.
abstract: The term monoclonal gammopathy of undetermined significance (MGUS) was coined in 1978. The recent advances in our knowledge about MGUS and smoldering multiple myeloma (SMM) have helped us better understand the pathogenesis of myeloma. It seems that myeloma evolves from a precursor state in almost all cases. We do not completely understand the multistep process from the precursor state to myeloma, but studies like whole genome sequencing continue to improve our understanding of this process. The process of transformation may not be linear acquisition of changes, but rather a branched heterogeneous process. Clinical features that are prognostic of rapid transformation have been identified, but no specific molecular markers have been identified. Even with recent advances, multiple myeloma remains an incurable disease in the vast majority, and intervening at the precursor state provides a unique opportunity to alter the natural history of the disease. A limitation is that a vast majority of patients with precursor disease, especially low-risk MGUS, will never progress to myeloma in their lifetime, and treating these patients is not only unnecessary but may be potentially harmful. The challenge is to identify a subset of patients with the precursor state that would definitely progress to myeloma and in whom interventions will have a meaningful impact. As our understanding of the molecular and genetic processes improves, these studies will guide the selection of high-risk patients more appropriately and ultimately direct a tailored management strategy to either delay progression to symptomatic myeloma or even "cure" a person at this premalignant stage.
authors.affiliation: Division of Hematology/Oncology, University of Arizona, Tuscon, Arizona 02215, USA.
authors.forename: Amit
authors.initials: A
authors.lastname: Agarwal
authors.forename: Irene M
authors.initials: IM
authors.lastname: Ghobrial
mesh_terms: D006801:Humans; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D009101:Multiple Myeloma / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors